搜索筛选:
搜索耗时3.2134秒,为你在为你在102,285,761篇论文里面共找到 14 篇相符的论文内容
类      型:
[期刊论文] 作者:Qiang Zhu,Shirui Mao, 来源:亚洲药物制剂科学(英文) 年份:2019
Lowdrug loading efficiency is one of themain obstacles hindering the application of contact lenses (CLs) as the carrier for extended ocular drug delivery. Here...
[期刊论文] 作者:Lan Zhang,Shirui Mao, 来源:亚洲药物制剂科学(英文) 年份:2016
Quality by Test (Qb T) was the only way to guarantee the quality of drug products before FDA launches current Good Manufacturing Practice (c GMP)[1], which is a...
[期刊论文] 作者:Yujiao Sun,Shirui Mao, 来源:亚洲药物制剂科学(英文) 年份:2016
Compatibility between drug and carrier is essential for improving drug loading in particulate drug delivery system.In the last few decades,computational approac...
[期刊论文] 作者:Lan Zhang,Shirui Mao, 来源:亚洲药物制剂科学(英文) 年份:2017
Quality by Test was the only way to guarantee quality of drug products before FDA launched current Good Manufacturing Practice. To clearly understand the manufa...
[期刊论文] 作者:Cuifang Cai,Shirui Mao,Thomas, 来源:亚洲药物制剂科学(英文) 年份:2016
Stabilization of proteins in delivery devices and design of appropriate protein carriers are major research issues due to the extreme sensitivity of proteins.Pr...
[会议论文] 作者:Linlin Wang,Ying Li,Shirui Mao, 来源:2nd Symposium on Innovative Polymers for Controlled Delivery 年份:2012
[会议论文] 作者:Dan Mei,Shirui Mao,Wei Sun, 来源:首届亚洲药物制剂科学研讨会(1st Asian Pharmaceutical Science and Technolog 年份:2007
Purpose:To investigate the effects of several absorption enhancers on the intranasal absorption of 2,3,5,6-tetramethylpyrazine phosphate (TMPP).Methods: An in situ nasal perfusion technique was used.R...
[会议论文] 作者:Wei Sun,Shirui Mao,Dan Mei, 来源:首届亚洲药物制剂科学研讨会(1st Asian Pharmaceutical Science and Technolog 年份:2007
Purpose: To synthesize and characterize chitosan-cysteine conjugates.Methods: Cysteine was covalently attached to chitosan via the formation of an amide bond.Results: The optimal coupling conditions w...
[会议论文] 作者:Chenjun Shi,Guoguang Wei,Chengyun Zhu,Shirui Mao, 来源:2014年中国药物制剂大会——中国药学会药剂专业委员会年会、第六届亚洲阿登制药技术研讨会暨国际控释协会中国分会年会 年份:2014
[会议论文] 作者:Chenjun Shi,Guoguang Wei,Chengyun Zhu,Shirui Mao, 来源:2014年中国药物制剂大会——中国药学会药剂专业委员会年会、第六届亚洲阿登制药技术研讨会暨国际控释协会中国分会年会 年份:2014
Objective: The aim of this study is to provide a theoretical method on the basis of Hansen solubility parameters (HSPs) for screening drug-polymer pairs in the early stage of grafted polymeric micelle...
[会议论文] 作者:Liang Li,Linlin Wang,Yang Shao,Shirui Mao, 来源:第一届生物颗粒制备技术与产业化应用技术研讨会 年份:2013
Purpose: The aim of this study was to better understand the underlying drug release characteristics from matrix tablets based on the combination of chitosan (CS) and different types of carrageenans (κ...
[会议论文] 作者:Chenjun Shi,Yujiao Sun,Guoguang Wei,Chengyun Zhu,Shirui Mao, 来源:纳米药物及纳米生物技术国际学术大会暨中国药学会纳米药物专业委员会成立大会 年份:2015
[会议论文] 作者:Shirui Mao,Yi Shi,Luk Li,Jing Xu,Andreas Schaper,Thomas Kissel, 来源:首届亚洲药物制剂科学研讨会(1st Asian Pharmaceutical Science and Technolog 年份:2007
Taking ABT627 as a hydrophobic model drug, poly-(lactic-co-glycolic acid) (PLGA) microspheres were prepared by an emulsion solvent evaporation method.Internal morphology of the microspheres was observ...
[期刊论文] 作者:Lu Qin,Haiyang Wu,Enyu Xu,Xin Zhang,Jian Guan,Ruizhi Zhao,Shirui Mao, 来源:亚洲药物制剂科学(英文) 年份:2021
Most biopharmaceutics classification system(BCS)class IV drugs,with poor solubility and inferior permeability,are also substrates of P-glycoprotein(P-gp)and cytochrome P450(CYP450),leading to their low oral bioavailability.The objective of ......
相关搜索: